安济盛生物

Located in Guangzhou Science City, Angitia Biopharmaceuticals is an innovative biotech focused on discovering and developing novel drugs for serious bone, muscle, and joint diseases. The company also operates in California, USA. The founder and core team members possess extensive experience in drug discovery, development, and management from both international and domestic large multinational corporations. The company's team comprises world-class scientists skilled in the pathophysiology of musculoskeletal diseases. Utilizing advanced genetic and molecular biology techniques, they uncover new mechanisms, signal transduction pathways, and their interactions, combined with computer-aided drug design, to identify new drug targets and develop novel biological and small molecule medications.

Angitia is dedicated to serving patients in need through innovative research, including internal R&D and collaborations with academic institutions and global biopharmaceutical companies. Our culture and work environment are open, inclusive, and compassionate. We welcome professionals who are competent, ambitious, and team-oriented to join our dynamic team.

Our mission is to discover, develop, and commercialize breakthrough therapeutics addressing critical unmet medical needs in serious musculoskeletal diseases.